본문 바로가기
KERD
논문KCI 등재

The growing burden of non-alcoholic fatty liver disease on mortality

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

참고문헌 (15)

  1. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
  2. Li J, "Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019 : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 4, pp.389~398 (2019)
  3. Younossi ZM, "The global epidemiology of nonalcoholic fatty liver disease(NAFLD)and nonalcoholic steatohepatitis(NASH) : a systematic review", Hepatology (2023)[DOI]
  4. Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회
  5. Peter Konyn, "Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.43~57 (2023), 대한간학회
  6. Kim D, "Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States", J Hepatol, 75, pp.1284~1291 (2021)
  7. Cheng Han Ng, "Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name", Clinical and Molecular Hepatology, 28(4), pp.790~801 (2022), 대한간학회
  8. Younossi ZM, "Are there outcome differences between NAFLD and metabolicassociated fatty liver disease?", Hepatology, 76, pp.1423~1437 (2022)
  9. de Avila L, "Nonalcoholic fatty liver disease is independently associated with higher all-cause and cause-specific mortality", Clin Gastroenterol Hepatol (2023)[DOI]
  10. Fu CE, "A metaanalysis on associated risk of mortality in nonalcoholic fatty liver disease", Endocr Pract, 29, pp.33~39 (2023)
  11. Eunji Ko, "Risk factors in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.79~85 (2023), 대한간학회
  12. Kim BK, "Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD", J Hepatol, 77, pp.1482~1490 (2022)
  13. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
  14. Younossi ZM, "AGA Clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease : Expert review", Gastroenterology, 160, pp.912~918 (2021)
  15. Theresa J. Hydes, "Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH", Clinical and Molecular Hepatology, 26(4), pp.383~400 (2020), 대한간학회[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (53건)